By analyzing the KEGG enrichment results, we know that Radix Astragali acts on osteosarcoma through multiple signaling pathways, such as IL-17 signaling pathway, PI3K-Akt signaling pathway, TNF signaling pathway and PD-L1 expression and PD-1 checkpoint pathway in cancer. Here, IL17A is linked to cancer.